We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
+21.24%
1 Year Est. Return
+31.15%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$337M
AUM Growth
+$38M
Cap. Flow
+$639K
Cap. Flow %
0.19%
Top 10 Hldgs %
24.39%
Holding
136
New
22
Increased
19
Reduced
34
Closed
27

Top Buys

Rank Stock Value
1
NVTA
Invitae Corporation
NVTA
+$6.82M
2
CRSP icon
CRISPR Therapeutics
CRSP
+$6.21M
3
EXAS
Exact Sciences
EXAS
+$5.59M
4
ARCT icon
Arcturus Therapeutics
ARCT
+$5.46M
5
PD icon
PagerDuty
PD
+$4.64M

Top Sells

Rank Stock Value
1
SSNC icon
SS&C Technologies
SSNC
+$4.58M
2
MSFT icon
Microsoft
MSFT
+$3.78M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.35M
4
SKX
Skechers
SKX
+$3M
5
FDX icon
FedEx
FDX
+$3M

Sector Composition

Rank Sector Weight
1 Healthcare 31.46%
2 Technology 27.99%
3 Communication Services 14.4%
4 Consumer Discretionary 7.67%
5 Industrials 6.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LMAT icon
76
LeMaitre Vascular
LMAT
$2.32B
$2.12M 0.63%
65,173
– –
WIRE
77
DELISTED
Encore Wire Corp
WIRE
$2.11M 0.63%
45,433
-6,720
-13% -$336K
INTU icon
78
Intuit
INTU
$86.5B
$2.07M 0.61%
6,359
– –
OSPN icon
79
OneSpan
OSPN
$574M
$2.06M 0.61%
+98,200
New +$2.42M
VAPO
80
DELISTED
Vapotherm, Inc. Common Stock
VAPO
$2.03M 0.6%
+8,750
New +$2.52M
MEDP icon
81
Medpace
MEDP
$16.1B
$1.98M 0.59%
17,698
– –
CPRT icon
82
Copart
CPRT
$27B
$1.96M 0.58%
74,488
-98,916
-57% -$2.4M
KURA icon
83
Kura Oncology
KURA
$800M
$1.91M 0.57%
62,331
– –
GEO icon
84
The GEO Group
GEO
$4.13B
$1.77M 0.53%
156,274
-10,000
-6% -$112K
MPT
85
Medical Properties Trust
MPT
$2.77B
$1.76M 0.52%
99,957
– –
SUPN icon
86
Supernus Pharmaceuticals
SUPN
$2.59B
$1.74M 0.52%
83,632
– –
PSNL icon
87
Personalis
PSNL
$1.35B
$1.74M 0.52%
+80,380
New +$1.6M
PI icon
88
Impinj
PI
$4.62B
$1.63M 0.48%
62,016
-8,000
-11% -$211K
OKTA icon
89
Okta
OKTA
$24.7B
$1.6M 0.48%
7,500
-10,000
-57% -$2.08M
EGRX
90
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.52M 0.45%
35,815
– –
SYRS
91
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.49M 0.44%
+16,860
New +$1.92M
GBT
92
DELISTED
Global Blood Therapeutics, Inc.
GBT
$1.45M 0.43%
26,362
-5,000
-16% -$318K
MPWR icon
93
Monolithic Power Systems
MPWR
$70.1B
$1.45M 0.43%
5,182
– –
AAPL icon
94
Apple
AAPL
$4.54T
$1.43M 0.42%
12,340
-18,000
-59% -$1.96M
ZM icon
95
Zoom
ZM
$28.2B
$1.41M 0.42%
+3,000
New +$959K
MMSI icon
96
Merit Medical Systems
MMSI
$5.08B
$1.39M 0.41%
31,915
– –
RNG icon
97
RingCentral
RNG
$4.66B
$1.37M 0.41%
5,000
-8,500
-63% -$2.36M
APPF icon
98
AppFolio
APPF
$6.38B
$1.37M 0.41%
9,658
+3,000
+45% +$462K
LVS icon
99
Las Vegas Sands
LVS
$31.7B
$1.16M 0.34%
24,929
-25,000
-50% -$1.19M
WT icon
100
WisdomTree
WT
$2.96B
$1.04M 0.31%
325,644
-640,137
-66% -$2.31M
2 3
4
5 6

Similar funds

AI
AXS Investments Port Chester, New York $248M AUM 15.95% 1-Year Est. Return
AB
ANB Bank Denver, Colorado $247M AUM 19.59% 1-Year Est. Return
PWS
Peloton Wealth Strategists Indianapolis, Indiana $247M AUM 13.57% 1-Year Est. Return
BFM
Blacksheep Fund Management Co. Dublin, Ireland $247M AUM 8.75% 1-Year Est. Return
IFPG
Intrepid Financial Planning Group Carmel, Indiana $248M AUM 19.02% 1-Year Est. Return
SCM
Segra Capital Management Palm Beach, Florida $248M AUM 65.61% 1-Year Est. Return
GWS
Greykasell Wealth Strategies Danville, California $248M AUM 22.08% 1-Year Est. Return
MC
Mount Capital London, United Kingdom $248M AUM 4.81% 1-Year Est. Return

Capital Impact Advisors's Q3 2020 Portfolio in Review

As of Q3 2020, Capital Impact Advisors held 136 positions worth $337M, up 13% from $299M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Capital Impact Advisors's Q3 2020 filing shows 22 new, 19 increased, 34 reduced and 27 closed positions. Its largest new stake was Invitae Corporation: 200,000 shares worth $8.67M. The largest sale was SS&C Technologies, an estimated $4.58M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 24% a quarter earlier, followed by Technology and Communication Services.

  • Capital Impact Advisors's largest Q3 2020 buy was Invitae Corporation: 200,000 shares worth $8.67M.
  • Capital Impact Advisors added most to Zillow in Q3 2020, an estimated $4.28M increase.
  • Capital Impact Advisors's biggest Q3 2020 reduction was Alphabet (Google) Class A, cutting an estimated $3.35M.
  • Capital Impact Advisors fully exited SS&C Technologies in Q3 2020, selling an estimated $4.58M.
  • Capital Impact Advisors's ten largest holdings make up 24% of its $337M portfolio in Q3 2020.
  • Capital Impact Advisors opened 22 new positions and closed 27 in Q3 2020.
  • Capital Impact Advisors's portfolio value rose 13% quarter-over-quarter to $337M.

Based on Capital Impact Advisors's 13F filing for Q3 2020, filed 13 Nov 2020.